Samsung Biologics to apply for S. Korea IPO approval
SEOUL: Samsung Biologics Co Ltd, the biopharmaceutical contract manufacturing affiliate of Samsung Group, is expected to apply on Aug 11 ...
Tag: Samsung Biologics to apply for S. Korea IPO approval
Popular Stories
-
FBR, Pakistan Customs express concerns over recent transfers & postings
-
Lahore Appraisement foils bid to smuggle goods, items worth Rs1.36b
-
MTBA seeks action for early disposal of pending cases in ATIR
-
PM Shehbaz directs FBR to defer implementation of SRO 350
-
FBR introduces SMS service 9966 to facilitate taxpayers